Congress Must Update FDA Regulations for Medical AI

This JAMA Forum discusses pending legislation in the US House and Senate and the history of the “firm-based approach” the US Food and Drug Administration (FDA) could use when regulating artificial intelligence (AI) medical devices to augment patient care.

from JAMA Health Forum New Online https://ift.tt/3VOCdsn